Fuji Pharma Co (4554.T) Stock Price
Fuji Pharma Co Price
Revenue has compounded at 8.4% per year over the past 19 years to 51.68 B JPY. Earnings per share have grown at 6.8% per year over the last 19 years. Fuji Pharma Co's net margin stands at 5.8%, down from 7.2% several years earlier. Fuji Pharma Co currently offers a dividend yield of about 2.26%. The payout ratio is around 35% of earnings. The dividend has grown at 12.2% per year over the past 14 years. Analysts set a median price target of 2,193.00 JPY, implying 16.8% above the current price. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Fuji Pharma Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Fuji Pharma Co business model & stock analysis
Frequently asked questions about Fuji Pharma Co
The business model of Fuji Pharma Co Ltd revolves around the pharmaceutical industry. Fuji Pharma Co Ltd is primarily engaged in the manufacturing and sales of various pharmaceutical products. The company focuses on developing and commercializing innovative drugs and medical devices, aiming to contribute to the improvement of global health. With a strong emphasis on research and development, Fuji Pharma Co Ltd aims to provide effective and safe medications to meet the healthcare needs of people worldwide. As a prominent player in the pharmaceutical sector, Fuji Pharma Co Ltd strives to maintain its position through continuous innovation, strategic collaborations, and customer-centric approaches.
Fuji Pharma Co Ltd is primarily active in the pharmaceutical industry.
The main competitors of Fuji Pharma Co Ltd in the market include companies such as Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Eisai Co., Ltd. These companies operate in the pharmaceutical industry and offer a range of products and services that compete with Fuji Pharma. Fuji Pharma Co Ltd is a reputable player in the market and faces competition from these well-established competitors in delivering innovative pharmaceutical solutions to customers.
Fuji Pharma Co Ltd, a renowned pharmaceutical company, has a rich history and robust background. Established in [year], it has consistently made notable contributions to the healthcare industry. With a strong focus on research and development, Fuji Pharma specializes in the development, manufacturing, and distribution of innovative pharmaceutical products. The company is committed to improving people's quality of life by offering a diverse range of high-quality medications and healthcare solutions. Fuji Pharma's dedication to excellence, customer satisfaction, and cutting-edge technology has positioned it as a leader in the industry. Their unwavering commitment to delivering effective healthcare solutions has earned them a stellar reputation among both healthcare professionals and patients alike.
Fuji Pharma Co Ltd has achieved significant milestones in its operations. The company has successfully expanded its product portfolio and gained recognition in the pharmaceutical industry. Through innovative research and development efforts, Fuji Pharma Co Ltd has introduced several breakthrough drugs and treatment options that have improved patients' lives. The company has also established valuable partnerships and collaborations with renowned global players, enhancing its market presence. Fuji Pharma Co Ltd's commitment to quality and innovation has earned it widespread acclaim and customer trust. As the company continues to excel in its journey, it remains dedicated to delivering cutting-edge pharmaceutical solutions that cater to diverse healthcare needs.
Fuji Pharma Co Ltd is primarily present in Japan.
Fuji Pharma Co Ltd represents values and a corporate philosophy centered around innovation, commitment to quality, and customer satisfaction. As a renowned pharmaceutical company, Fuji Pharma prioritizes research and development to deliver cutting-edge treatments and healthcare solutions. With a focus on improving global health, the company operates with integrity, ethical business practices, and compliance with regulatory standards. Fuji Pharma Co Ltd aims to contribute to society by providing reliable and safe pharmaceutical products that enhance the health and well-being of individuals worldwide.
Analysts currently set an average price target of 2,193.00 JPY for the Fuji Pharma Co stock (median: 2,193.00 JPY), implying +16.8 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Fuji Pharma Co stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Fuji Pharma Co to generate revenue of 63.00 B JPY and earnings per share of 95.49 JPY.
Converted at the current exchange rate, the Fuji Pharma Co share trades at 10.60 EUR (1,878.00 JPY).
The Fuji Pharma Co share (4554.T) is listed on 2 stock exchanges, including: Tokio (JPX) (4554.T), Frankfurt (FUP.F).
Fuji Pharma Co Ltd is a Japanese company that was founded in 1950. The company is primarily engaged in the manufacture and sale of pharmaceuticals, medical devices, and cosmetics. They have several business areas to meet the various needs of consumers.
The expected revenue of Fuji Pharma Co is 63.00 B JPY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Fuji Pharma Co is 2.34 B JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Fuji Pharma Co is currently 19.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Fuji Pharma Co stock.
The price-to-sales ratio (P/S) of Fuji Pharma Co is currently 0.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Fuji Pharma Co stock.
The Eulerpool Quality Score for Fuji Pharma Co is 7/10.
The ISIN of Fuji Pharma Co is JP3816200004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Fuji Pharma Co is 938283. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Fuji Pharma Co is 4554.T. The ticker symbol is used to trade Fuji Pharma Co shares on the stock exchange.
Fuji Pharma Co stock
Fuji Pharma Co Peer Group
Fuji Pharma Co Ticker
Fuji Pharma Co FIGI
All fundamentals and in-depth analysis of Fuji Pharma Co
Our stock analysis for Fuji Pharma Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuji Pharma Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.